A. H. Loonen

Mutations in KIT and RAS are frequent events in pediatric core-binding factor acute myeloid leukemia

Bianca F. Goemans, Ch. M. Zwaan, Mitchell Miller et al. · Leukemia · 2005 · 239 citations · Full text

Hematological Malignancy, Chromatin, Pediatric Hematology +8

Relation of cellular drug resistance to long-term clinical outcome in childhood acute lymphoblastic leukaemia

Rob Pieters, D. R. Huismans, A. H. Loonen et al. · The Lancet · 1991 · 223 citations

Hematological Malignancy, Health Sciences, Pediatric Hematology +12

TEL/AML1 gene fusion is related to in vitro drug sensitivity for L-asparaginase in childhood acute lymphoblastic leukemia.

N. L. Ramakers-Van Woerden, R. Pieters, A. H. Loonen et al. · PubMed · 2000 · 151 citations

A Genome-Wide View of the <i>In vitro</i> Response to <scp>l</scp>-Asparaginase in Acute Lymphoblastic Leukemia

Bernard M. Fine, Gertjan J.L. Kaspers, Minh Ho et al. · Cancer Research · 2005 · 102 citations · Full text

Chromatin, Systems Biology, Functional Genomics +13

In vitro drug-resistance profile in infant acute lymphoblastic leukemia in relation to age, MLL rearrangements and immunophenotype

N. L. Ramakers-Van Woerden, H. Berna Beverloo, A. Veerman et al. · Leukemia · 2004 · 89 citations · Full text

Hematological Malignancy, Health Sciences, Medicine +10